https://www.pharmaceutical-technology.com/data-insights/ilyx-002-iolyx-therapeutics-keratoconjunctivitis-sicca-dry-eye-likelihood-of-approval/
ILYX-002 is under clinical development by Iolyx Therapeutics and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye).
keratoconjunctivitis siccadry eyetherapeutics
https://pubmed.ncbi.nlm.nih.gov/24342754/
Atopic keratoconjunctivitis is a chronic noninfectious inflammatory condition and is one of the most severe ophthalmic complications associated with atopic...
atopickeratoconjunctivitisreview
https://www.merckvetmanual.com/eye-diseases-and-disorders/infectious-keratoconjunctivitis/infectious-keratoconjunctivitis-in-cattle-and-small-ruminants?sccamp=sccamp
Apr 10, 2024 - Learn about the veterinary topic of Infectious Keratoconjunctivitis in Cattle and Small Ruminants. Find specific details on this topic and related topics from...
small ruminantseye diseasesinfectiouskeratoconjunctivitiscattle
https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-keratoconjunctivitis-sicca-dry-eye/
Keratoconjunctivitis Sicca (Dry Eye) disease is an indication for drug development with over 170 pipeline drugs currently active according to GlobalData.
keratoconjunctivitis siccadry eyedrugslikelihoodapproval
https://www.pharmaceutical-technology.com/data-insights/shj-002-sunhawk-vision-biotech-keratoconjunctivitis-sicca-dry-eye-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-214821&utm_campaign=recommended-articles-pi
SHJ-002is under clinical development by Sunhawk Vision Biotech and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye).
keratoconjunctivitis siccashjvisionbiotechdry